全文获取类型
收费全文 | 32707篇 |
免费 | 2109篇 |
国内免费 | 96篇 |
专业分类
耳鼻咽喉 | 491篇 |
儿科学 | 812篇 |
妇产科学 | 372篇 |
基础医学 | 4165篇 |
口腔科学 | 474篇 |
临床医学 | 3291篇 |
内科学 | 7526篇 |
皮肤病学 | 212篇 |
神经病学 | 3512篇 |
特种医学 | 1345篇 |
外科学 | 5362篇 |
综合类 | 289篇 |
一般理论 | 72篇 |
预防医学 | 2278篇 |
眼科学 | 422篇 |
药学 | 1968篇 |
中国医学 | 22篇 |
肿瘤学 | 2299篇 |
出版年
2023年 | 165篇 |
2022年 | 291篇 |
2021年 | 730篇 |
2020年 | 419篇 |
2019年 | 719篇 |
2018年 | 864篇 |
2017年 | 602篇 |
2016年 | 694篇 |
2015年 | 793篇 |
2014年 | 1147篇 |
2013年 | 1463篇 |
2012年 | 2368篇 |
2011年 | 2435篇 |
2010年 | 1404篇 |
2009年 | 1164篇 |
2008年 | 2187篇 |
2007年 | 2284篇 |
2006年 | 2197篇 |
2005年 | 2188篇 |
2004年 | 1957篇 |
2003年 | 1849篇 |
2002年 | 1800篇 |
2001年 | 327篇 |
2000年 | 270篇 |
1999年 | 323篇 |
1998年 | 366篇 |
1997年 | 295篇 |
1996年 | 239篇 |
1995年 | 248篇 |
1994年 | 204篇 |
1993年 | 187篇 |
1992年 | 196篇 |
1991年 | 195篇 |
1990年 | 179篇 |
1989年 | 151篇 |
1988年 | 135篇 |
1987年 | 134篇 |
1986年 | 131篇 |
1985年 | 138篇 |
1984年 | 166篇 |
1983年 | 135篇 |
1982年 | 149篇 |
1981年 | 128篇 |
1980年 | 105篇 |
1979年 | 80篇 |
1978年 | 75篇 |
1977年 | 67篇 |
1974年 | 50篇 |
1973年 | 47篇 |
1972年 | 56篇 |
排序方式: 共有10000条查询结果,搜索用时 11 毫秒
1.
2.
Implications for Practice
Breast cancer is far more curable than in the past but requires multimodality treatment. Great care must be taken to use the least leukemogenic treatment programs that do not sacrifice efficacy. Elimination of radiation and anthracycline/alkylating agent regimens will be helpful where possible, particularly in younger patients and possibly those with homologous repair deficiency (HRD). Use of colony-stimulating factors should be limited to those who truly require them for safe chemotherapy administration. Further study of a possible leukemogenic association with HRD and the various forms of colony-stimulating factors is badly needed.3.
4.
5.
6.
Elevated levels of the NR2C subunit of the NMDA receptor in the locus coeruleus in depression. 总被引:2,自引:0,他引:2
Low levels of the intracellular mediator of glutamate receptor activation, neuronal nitric oxide synthase (nNOS) were previously observed in locus coeruleus (LC) from subjects diagnosed with major depression. This finding implicates abnormalities in glutamate signaling in depression. Receptors responding to glutamate in the LC include ionotropic N-methyl-D-aspartate receptors (NMDARs). The functional NMDAR is a hetero-oligomeric structure composed of NR1 and NR2 (A-D) subunits. Tissue containing the LC and a nonlimbic LC projection area (cerebellum) was obtained from 13 and 9 matched pairs, respectively, of depressed subjects and control subjects lacking major psychiatric diagnoses. NMDAR subunit composition in the LC was evaluated in a psychiatrically normal subject. NR1 and NR2C subunit immunoreactivities in LC homogenates showed prominent bands at 120 and 135 kDa, respectively. In contrast to NRI and NR2C, very weak immunoreactivity of NR2A and NR2B subunits was observed in the LC. Possible changes in concentrations of NR1 and NR2C that might occur in depression were assessed in the LC and cerebellum. The overall amount of NR1 immunoreactivity was normal in the LC and cerebellum in depressed subjects. Amounts of NR2C protein were significantly higher (+ 61%, p = 0.003) in the LC and modestly, but not significantly, elevated in the cerebellum (+ 35%) of depressives as compared to matched controls. Higher levels of NR2C subunit implicate altered glutamatergic input to the LC in depressive disorders. 相似文献
7.
8.
Anthony Spirito Larry Brown James Overholser Gregory Fritz Andrea Bond 《Death Studies》1991,15(3):269-280
The assessment of the medical lethality and intent of suicide attempts has been considered an important area of research for those interested in suicide. The current study examined the usefulness of the Risk-Rescue Rating Scale with 109 adolescent suicide attempters and found a restricted range of variability, which, in turn, resulted in poor interrater reliability on a number of items. Results suggest that the Risk-Rescue Rating Scale is of limited usefulness with adolescents, and alternative approaches to assessing lethality and suicidal intent with this age group are discussed. 相似文献
9.
Najat C Daw Wayne L Furman Clinton F Stewart Lisa C Iacono Mark Krailo Mark L Bernstein Janet E Dancey Rose Anne Speights Susan M Blaney James M Croop Gregory H Reaman Peter C Adamson 《Journal of clinical oncology》2005,23(25):6172-6180
PURPOSE: Epidermal growth factor receptor is expressed in pediatric malignant solid tumors. We conducted a phase I trial of gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, in children with refractory solid tumors. PATIENTS AND METHODS: Gefitinib (150, 300, 400, or 500 mg/m2) was administered orally to cohorts of three to six patients once daily continuously until disease progression or significant toxicity. Pharmacokinetic studies were performed during course one (day 1 through 28). RESULTS: Of the 25 enrolled patients, 19 (median age, 15 years) were fully evaluable for toxicity and received 54 courses. Dose-limiting toxicity was rash in two patients treated with 500 mg/m2 and elevated ALT and AST in one patient treated with 400 mg/m2. The maximum-tolerated dose was 400 mg/m2/d. The most frequent non-dose-limiting toxicities were grade 1 or 2 dry skin, anemia, diarrhea, nausea, and vomiting. One patient with Ewing's sarcoma had a partial response. Disease stabilized for 8 to > or = 60 weeks in two patients with Wilms' tumor and two with brainstem glioma (one exophytic). At 400 mg/m2, the median peak gefitinib plasma concentration was 2.2 microg/mL (range, 1.2 to 3.6 microg/mL) and occurred at a median of 2.3 hours (range, 2.0 to 8.3 hours) after drug administration. The median apparent clearance and median half-life were 14.8 L/h/m2 (range, 3.8 to 24.8 L/h/m2) and 11.7 hours (range, 5.6 to 22.8 hours), respectively. Gefitinib systemic exposures were comparable with those associated with antitumor activity in adults. CONCLUSION: Oral gefitinib is well tolerated in children. Development of the drug in combination with cytotoxic chemotherapy will be pursued. 相似文献
10.